Starpharma Holdings Limited
ASX:SPL.AX
Overview | Financials
Company Name | Starpharma Holdings Limited |
Symbol | SPL.AX |
Currency | AUD |
Price | 0.098 |
Market Cap | 40,902,064 |
Dividend Yield | 0% |
52-week-range | 0.086 - 0.195 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), GAICD, MBA |
Website | https://starpharma.com |
An error occurred while fetching data.
About Starpharma Holdings Limited
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD